FI48930B - - Google Patents

Info

Publication number
FI48930B
FI48930B FI02252/68A FI225268A FI48930B FI 48930 B FI48930 B FI 48930B FI 02252/68 A FI02252/68 A FI 02252/68A FI 225268 A FI225268 A FI 225268A FI 48930 B FI48930 B FI 48930B
Authority
FI
Finland
Application number
FI02252/68A
Other languages
Finnish (fi)
Other versions
FI48930C (fi
Inventor
W Hoyle
G Howarth
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of FI48930B publication Critical patent/FI48930B/fi
Publication of FI48930C publication Critical patent/FI48930C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI682252A 1967-08-26 1968-08-09 Menetelmä 3-(5-nitro-2-furyyli)-2-isoksatsoliinien uusien terapeuttise sti aktiivisten johdannaisten valmistamiseksi. FI48930C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3935167 1967-08-26

Publications (2)

Publication Number Publication Date
FI48930B true FI48930B (enExample) 1974-10-31
FI48930C FI48930C (fi) 1975-02-10

Family

ID=10409082

Family Applications (1)

Application Number Title Priority Date Filing Date
FI682252A FI48930C (fi) 1967-08-26 1968-08-09 Menetelmä 3-(5-nitro-2-furyyli)-2-isoksatsoliinien uusien terapeuttise sti aktiivisten johdannaisten valmistamiseksi.

Country Status (18)

Country Link
US (1) US3769295A (enExample)
JP (1) JPS4827310B1 (enExample)
AT (1) AT277221B (enExample)
BE (1) BE719891A (enExample)
CA (1) CA933926A (enExample)
CH (1) CH502372A (enExample)
CS (1) CS157037B2 (enExample)
DE (1) DE1795208A1 (enExample)
DK (1) DK118820B (enExample)
ES (1) ES357511A1 (enExample)
FI (1) FI48930C (enExample)
FR (2) FR1589115A (enExample)
GB (1) GB1234213A (enExample)
IE (1) IE32300B1 (enExample)
NL (2) NL6811722A (enExample)
NO (1) NO125931B (enExample)
SE (1) SE330540B (enExample)
YU (1) YU199068A (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915978A (en) * 1970-01-07 1975-10-28 Merck & Co Inc Nitroimidazoles
US4010176A (en) * 1972-10-27 1977-03-01 Merck & Co., Inc. Isoxazole substituted nitroimidazoles
US4203994A (en) * 1976-06-14 1980-05-20 Eli Lilly And Company Fungicidal 3-phenyl-5-(substituted methyl)isoxazoles
US4109002A (en) * 1976-06-14 1978-08-22 Eli Lilly And Company Fungicidal 3-phenyl-5-(substituted methyl) isoxaxoles
IL85691A0 (en) * 1987-04-10 1988-08-31 Pennwalt Corp 5-(phenyl or phenoxymethyl)-3-(2-furanyl or 2-thienyl)-3-(1h-imidazol-1-ylmethyl)-2-methylisoxazolidines and salts thereof
JP2000516245A (ja) * 1996-08-21 2000-12-05 ファルマシア・アンド・アップジョン・カンパニー 抗菌剤として有用なイソオキサゾリン誘導体類
PT1054874E (pt) * 1998-02-13 2003-01-31 Upjohn Co Derivados de aminofenil-isoxazolina substituidos uteis como anti-microbianos
JP2002504550A (ja) * 1998-02-25 2002-02-12 ファルマシア・アンド・アップジョン・カンパニー 抗微生物剤として有用な置換アミノメチルイソオキサゾリン誘導体
EP1349853B1 (en) * 2000-12-21 2006-03-08 Pharmacia & Upjohn Company LLC Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
JP2005512975A (ja) * 2001-10-25 2005-05-12 アストラゼネカ アクチボラグ 抗菌薬として有用なイソキサゾリン誘導体
WO2003035648A1 (en) * 2001-10-25 2003-05-01 Astrazeneca Ab Aryl substituted oxazolidinones with antibacterial activity
CN101774976B (zh) * 2010-01-26 2012-05-09 天津药物研究院 磺酰基异噁唑啉衍生物及抗肿瘤用途
CN101781294B (zh) * 2010-03-10 2012-02-01 天津药物研究院 一类咪唑的衍生物、其制备方法和用途
US10106509B2 (en) * 2015-02-27 2018-10-23 Op Bio Factory Co., Ltd. Method for producing kakeromycin and derivatives thereof

Also Published As

Publication number Publication date
FI48930C (fi) 1975-02-10
GB1234213A (enExample) 1971-06-03
CS157037B2 (enExample) 1974-08-23
US3769295A (en) 1973-10-30
FR1589115A (enExample) 1970-03-23
DE1795208A1 (de) 1972-03-16
IE32300L (en) 1969-02-26
IE32300B1 (en) 1973-06-13
BE719891A (enExample) 1969-02-24
ES357511A1 (es) 1970-03-16
JPS4827310B1 (enExample) 1973-08-21
AT277221B (de) 1969-12-10
CH502372A (de) 1971-01-31
FR8102M (enExample) 1970-07-27
YU199068A (en) 1978-05-15
CA933926A (en) 1973-09-18
NL6811722A (enExample) 1969-02-28
SE330540B (enExample) 1970-11-23
NO125931B (enExample) 1972-11-27
NL137326C (enExample)
DK118820B (da) 1970-10-12

Similar Documents

Publication Publication Date Title
FR1589115A (enExample)
BE707890R (enExample)
AU416737B2 (enExample)
BE711362A (enExample)
BE709345A (enExample)
BE711088A (enExample)
BE709713A (enExample)
BE711776A (enExample)
BE709116A (enExample)
BE693472A (enExample)
BE709629A (enExample)
BE711847A (enExample)
BE711725A (enExample)
BE709740A (enExample)
BE711296A (enExample)
BE709994A (enExample)
BE710805A (enExample)
BE707252A (enExample)
BE701835A (enExample)
BE708912A (enExample)
BE711399A (enExample)
BE708122A (enExample)
BE709505A (enExample)
BE701842A (enExample)
BE710795A (enExample)